Comparative Evaluation of FET and FDG for Differentiating Lung Carcinoma from Inflammation in Mice

Background: Clinical FDG/PET (2-deoxy-2- 18 F-fluoro-D-glucose/positron emission tomography) studies encounter difficulties in detecting early stage lung cancers. The aim of this study was to evaluate the ability of O-2- 18 F-fluoroethyl-L-tyrosine (FET) and FDG to differentiate between inflammation...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Anticancer research 2006-03, Vol.26 (2A), p.917-925
Hauptverfasser: CHANG, Chih-Hsien, WANG, Hsin-Ell, FU, Ying-Kai, WU, Shi-Yuan, FAN, Kuo-Hsien, TSAI, Tung-Hu, LEE, Te-Wei, CHANG, Shiang-Rong, LIU, Ren-Shyan, CHEN, Chieh-Fu, CHEN, Chin-Hsiung
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 925
container_issue 2A
container_start_page 917
container_title Anticancer research
container_volume 26
creator CHANG, Chih-Hsien
WANG, Hsin-Ell
FU, Ying-Kai
WU, Shi-Yuan
FAN, Kuo-Hsien
TSAI, Tung-Hu
LEE, Te-Wei
CHANG, Shiang-Rong
LIU, Ren-Shyan
CHEN, Chieh-Fu
CHEN, Chin-Hsiung
description Background: Clinical FDG/PET (2-deoxy-2- 18 F-fluoro-D-glucose/positron emission tomography) studies encounter difficulties in detecting early stage lung cancers. The aim of this study was to evaluate the ability of O-2- 18 F-fluoroethyl-L-tyrosine (FET) and FDG to differentiate between inflammation and lung carcinoma in mice. Materials and Methods: Sixty-four C57BL/6 mice were inoculated with 2x10 6 LLC1 lung carcinoma cells in the right hind flank on day 0 and were then injected with 0.1 mL turpentine in the left thigh muscle on day 3. The progress of inflammation and tumor in mice was longitudinally monitored by FDG/microPET. The biodistribution study, pharmacokinetic evaluation and whole-body autoradiography of FET and FDG were performed on day 8 after tumor inoculation. Results: The FDG uptakes in tumor and inflammatory lesions were 4.42-fold and 3.53-fold (n=4) higher, respectively, than that in muscle at 90 min post-injection and the tumor-to-inflammation ratio was 1.25. For FET/microPET, the tumor uptake was 2.07-fold and 2.07-fold (n=4) higher than those in muscle and inflammatory lesions at 90 min post-injection, respectively. The distribution half-life (t 1/2,α ) and the elimination half-life (t 1/2,β ) of FET were 39 min and 205 min, respectively, in mice. Conclusion: FDG delineated both tumor and inflammation, while FET accumulated in tumor to a significantly higher extent. Our results demonstrated the potential of FET to distinguish epidermoid lung carcinoma from inflammatory lesions in mice.
format Article
fullrecord <record><control><sourceid>pubmed_pasca</sourceid><recordid>TN_cdi_pubmed_primary_16619487</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>16619487</sourcerecordid><originalsourceid>FETCH-LOGICAL-h269t-b242777e2e6445acfed08b566cf7981fa227561bb433330c950499e9928326433</originalsourceid><addsrcrecordid>eNpFj8tqwzAQRUVpadK0v1C06dIgyZZkLYPzhJRu2rUZy1KsYslBTlL69xUkJbO4dxgOB-YOTalUNJM8J_doShgnmSSET9DTOH4TIoQq80c0oUJQVZRyippq8AeIcHRng5dn6E9pHQIeLF4tPzGEFq8Wa2yHiBfOWhNNOLqEhD3enVJUELULgwds4-DxNtgevL84XMDvTptn9GChH83LtWfoK6mrTbb7WG-r-S7rmFDHrGEFk1IaZkRRcNDWtKRsuBDaSlVSC4xJLmjTFHkaohUnhVJGKVbmTKTjDL1evIdT401bH6LzEH_r_2cT8HYFYNTQ2whBu_HGSSFLRdWN69y--3HR1KOHvk_avIbIRM3mtaIy_wMeBWm9</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Comparative Evaluation of FET and FDG for Differentiating Lung Carcinoma from Inflammation in Mice</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>CHANG, Chih-Hsien ; WANG, Hsin-Ell ; FU, Ying-Kai ; WU, Shi-Yuan ; FAN, Kuo-Hsien ; TSAI, Tung-Hu ; LEE, Te-Wei ; CHANG, Shiang-Rong ; LIU, Ren-Shyan ; CHEN, Chieh-Fu ; CHEN, Chin-Hsiung</creator><creatorcontrib>CHANG, Chih-Hsien ; WANG, Hsin-Ell ; FU, Ying-Kai ; WU, Shi-Yuan ; FAN, Kuo-Hsien ; TSAI, Tung-Hu ; LEE, Te-Wei ; CHANG, Shiang-Rong ; LIU, Ren-Shyan ; CHEN, Chieh-Fu ; CHEN, Chin-Hsiung</creatorcontrib><description>Background: Clinical FDG/PET (2-deoxy-2- 18 F-fluoro-D-glucose/positron emission tomography) studies encounter difficulties in detecting early stage lung cancers. The aim of this study was to evaluate the ability of O-2- 18 F-fluoroethyl-L-tyrosine (FET) and FDG to differentiate between inflammation and lung carcinoma in mice. Materials and Methods: Sixty-four C57BL/6 mice were inoculated with 2x10 6 LLC1 lung carcinoma cells in the right hind flank on day 0 and were then injected with 0.1 mL turpentine in the left thigh muscle on day 3. The progress of inflammation and tumor in mice was longitudinally monitored by FDG/microPET. The biodistribution study, pharmacokinetic evaluation and whole-body autoradiography of FET and FDG were performed on day 8 after tumor inoculation. Results: The FDG uptakes in tumor and inflammatory lesions were 4.42-fold and 3.53-fold (n=4) higher, respectively, than that in muscle at 90 min post-injection and the tumor-to-inflammation ratio was 1.25. For FET/microPET, the tumor uptake was 2.07-fold and 2.07-fold (n=4) higher than those in muscle and inflammatory lesions at 90 min post-injection, respectively. The distribution half-life (t 1/2,α ) and the elimination half-life (t 1/2,β ) of FET were 39 min and 205 min, respectively, in mice. Conclusion: FDG delineated both tumor and inflammation, while FET accumulated in tumor to a significantly higher extent. Our results demonstrated the potential of FET to distinguish epidermoid lung carcinoma from inflammatory lesions in mice.</description><identifier>ISSN: 0250-7005</identifier><identifier>EISSN: 1791-7530</identifier><identifier>PMID: 16619487</identifier><language>eng</language><publisher>Attiki: International Institute of Anticancer Research</publisher><subject>Animals ; Autoradiography - methods ; Biological and medical sciences ; Carcinoma, Lewis Lung - diagnostic imaging ; Carcinoma, Lewis Lung - metabolism ; Carcinoma, Non-Small-Cell Lung - diagnostic imaging ; Carcinoma, Non-Small-Cell Lung - metabolism ; Diagnosis, Differential ; Fluorine Radioisotopes ; Fluorodeoxyglucose F18 - pharmacokinetics ; Image Processing, Computer-Assisted ; Lung Neoplasms - diagnostic imaging ; Lung Neoplasms - metabolism ; Male ; Medical sciences ; Mice ; Mice, Inbred C57BL ; Pneumology ; Pneumonia - chemically induced ; Pneumonia - diagnostic imaging ; Pneumonia - metabolism ; Positron-Emission Tomography - methods ; Radiopharmaceuticals - pharmacokinetics ; Tumors ; Tumors of the respiratory system and mediastinum ; Turpentine ; Tyrosine - analogs &amp; derivatives ; Tyrosine - pharmacokinetics</subject><ispartof>Anticancer research, 2006-03, Vol.26 (2A), p.917-925</ispartof><rights>2006 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=17678919$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16619487$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>CHANG, Chih-Hsien</creatorcontrib><creatorcontrib>WANG, Hsin-Ell</creatorcontrib><creatorcontrib>FU, Ying-Kai</creatorcontrib><creatorcontrib>WU, Shi-Yuan</creatorcontrib><creatorcontrib>FAN, Kuo-Hsien</creatorcontrib><creatorcontrib>TSAI, Tung-Hu</creatorcontrib><creatorcontrib>LEE, Te-Wei</creatorcontrib><creatorcontrib>CHANG, Shiang-Rong</creatorcontrib><creatorcontrib>LIU, Ren-Shyan</creatorcontrib><creatorcontrib>CHEN, Chieh-Fu</creatorcontrib><creatorcontrib>CHEN, Chin-Hsiung</creatorcontrib><title>Comparative Evaluation of FET and FDG for Differentiating Lung Carcinoma from Inflammation in Mice</title><title>Anticancer research</title><addtitle>Anticancer Res</addtitle><description>Background: Clinical FDG/PET (2-deoxy-2- 18 F-fluoro-D-glucose/positron emission tomography) studies encounter difficulties in detecting early stage lung cancers. The aim of this study was to evaluate the ability of O-2- 18 F-fluoroethyl-L-tyrosine (FET) and FDG to differentiate between inflammation and lung carcinoma in mice. Materials and Methods: Sixty-four C57BL/6 mice were inoculated with 2x10 6 LLC1 lung carcinoma cells in the right hind flank on day 0 and were then injected with 0.1 mL turpentine in the left thigh muscle on day 3. The progress of inflammation and tumor in mice was longitudinally monitored by FDG/microPET. The biodistribution study, pharmacokinetic evaluation and whole-body autoradiography of FET and FDG were performed on day 8 after tumor inoculation. Results: The FDG uptakes in tumor and inflammatory lesions were 4.42-fold and 3.53-fold (n=4) higher, respectively, than that in muscle at 90 min post-injection and the tumor-to-inflammation ratio was 1.25. For FET/microPET, the tumor uptake was 2.07-fold and 2.07-fold (n=4) higher than those in muscle and inflammatory lesions at 90 min post-injection, respectively. The distribution half-life (t 1/2,α ) and the elimination half-life (t 1/2,β ) of FET were 39 min and 205 min, respectively, in mice. Conclusion: FDG delineated both tumor and inflammation, while FET accumulated in tumor to a significantly higher extent. Our results demonstrated the potential of FET to distinguish epidermoid lung carcinoma from inflammatory lesions in mice.</description><subject>Animals</subject><subject>Autoradiography - methods</subject><subject>Biological and medical sciences</subject><subject>Carcinoma, Lewis Lung - diagnostic imaging</subject><subject>Carcinoma, Lewis Lung - metabolism</subject><subject>Carcinoma, Non-Small-Cell Lung - diagnostic imaging</subject><subject>Carcinoma, Non-Small-Cell Lung - metabolism</subject><subject>Diagnosis, Differential</subject><subject>Fluorine Radioisotopes</subject><subject>Fluorodeoxyglucose F18 - pharmacokinetics</subject><subject>Image Processing, Computer-Assisted</subject><subject>Lung Neoplasms - diagnostic imaging</subject><subject>Lung Neoplasms - metabolism</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Pneumology</subject><subject>Pneumonia - chemically induced</subject><subject>Pneumonia - diagnostic imaging</subject><subject>Pneumonia - metabolism</subject><subject>Positron-Emission Tomography - methods</subject><subject>Radiopharmaceuticals - pharmacokinetics</subject><subject>Tumors</subject><subject>Tumors of the respiratory system and mediastinum</subject><subject>Turpentine</subject><subject>Tyrosine - analogs &amp; derivatives</subject><subject>Tyrosine - pharmacokinetics</subject><issn>0250-7005</issn><issn>1791-7530</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFj8tqwzAQRUVpadK0v1C06dIgyZZkLYPzhJRu2rUZy1KsYslBTlL69xUkJbO4dxgOB-YOTalUNJM8J_doShgnmSSET9DTOH4TIoQq80c0oUJQVZRyippq8AeIcHRng5dn6E9pHQIeLF4tPzGEFq8Wa2yHiBfOWhNNOLqEhD3enVJUELULgwds4-DxNtgevL84XMDvTptn9GChH83LtWfoK6mrTbb7WG-r-S7rmFDHrGEFk1IaZkRRcNDWtKRsuBDaSlVSC4xJLmjTFHkaohUnhVJGKVbmTKTjDL1evIdT401bH6LzEH_r_2cT8HYFYNTQ2whBu_HGSSFLRdWN69y--3HR1KOHvk_avIbIRM3mtaIy_wMeBWm9</recordid><startdate>20060301</startdate><enddate>20060301</enddate><creator>CHANG, Chih-Hsien</creator><creator>WANG, Hsin-Ell</creator><creator>FU, Ying-Kai</creator><creator>WU, Shi-Yuan</creator><creator>FAN, Kuo-Hsien</creator><creator>TSAI, Tung-Hu</creator><creator>LEE, Te-Wei</creator><creator>CHANG, Shiang-Rong</creator><creator>LIU, Ren-Shyan</creator><creator>CHEN, Chieh-Fu</creator><creator>CHEN, Chin-Hsiung</creator><general>International Institute of Anticancer Research</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope></search><sort><creationdate>20060301</creationdate><title>Comparative Evaluation of FET and FDG for Differentiating Lung Carcinoma from Inflammation in Mice</title><author>CHANG, Chih-Hsien ; WANG, Hsin-Ell ; FU, Ying-Kai ; WU, Shi-Yuan ; FAN, Kuo-Hsien ; TSAI, Tung-Hu ; LEE, Te-Wei ; CHANG, Shiang-Rong ; LIU, Ren-Shyan ; CHEN, Chieh-Fu ; CHEN, Chin-Hsiung</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-h269t-b242777e2e6445acfed08b566cf7981fa227561bb433330c950499e9928326433</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Animals</topic><topic>Autoradiography - methods</topic><topic>Biological and medical sciences</topic><topic>Carcinoma, Lewis Lung - diagnostic imaging</topic><topic>Carcinoma, Lewis Lung - metabolism</topic><topic>Carcinoma, Non-Small-Cell Lung - diagnostic imaging</topic><topic>Carcinoma, Non-Small-Cell Lung - metabolism</topic><topic>Diagnosis, Differential</topic><topic>Fluorine Radioisotopes</topic><topic>Fluorodeoxyglucose F18 - pharmacokinetics</topic><topic>Image Processing, Computer-Assisted</topic><topic>Lung Neoplasms - diagnostic imaging</topic><topic>Lung Neoplasms - metabolism</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Pneumology</topic><topic>Pneumonia - chemically induced</topic><topic>Pneumonia - diagnostic imaging</topic><topic>Pneumonia - metabolism</topic><topic>Positron-Emission Tomography - methods</topic><topic>Radiopharmaceuticals - pharmacokinetics</topic><topic>Tumors</topic><topic>Tumors of the respiratory system and mediastinum</topic><topic>Turpentine</topic><topic>Tyrosine - analogs &amp; derivatives</topic><topic>Tyrosine - pharmacokinetics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>CHANG, Chih-Hsien</creatorcontrib><creatorcontrib>WANG, Hsin-Ell</creatorcontrib><creatorcontrib>FU, Ying-Kai</creatorcontrib><creatorcontrib>WU, Shi-Yuan</creatorcontrib><creatorcontrib>FAN, Kuo-Hsien</creatorcontrib><creatorcontrib>TSAI, Tung-Hu</creatorcontrib><creatorcontrib>LEE, Te-Wei</creatorcontrib><creatorcontrib>CHANG, Shiang-Rong</creatorcontrib><creatorcontrib>LIU, Ren-Shyan</creatorcontrib><creatorcontrib>CHEN, Chieh-Fu</creatorcontrib><creatorcontrib>CHEN, Chin-Hsiung</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>Anticancer research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>CHANG, Chih-Hsien</au><au>WANG, Hsin-Ell</au><au>FU, Ying-Kai</au><au>WU, Shi-Yuan</au><au>FAN, Kuo-Hsien</au><au>TSAI, Tung-Hu</au><au>LEE, Te-Wei</au><au>CHANG, Shiang-Rong</au><au>LIU, Ren-Shyan</au><au>CHEN, Chieh-Fu</au><au>CHEN, Chin-Hsiung</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Comparative Evaluation of FET and FDG for Differentiating Lung Carcinoma from Inflammation in Mice</atitle><jtitle>Anticancer research</jtitle><addtitle>Anticancer Res</addtitle><date>2006-03-01</date><risdate>2006</risdate><volume>26</volume><issue>2A</issue><spage>917</spage><epage>925</epage><pages>917-925</pages><issn>0250-7005</issn><eissn>1791-7530</eissn><abstract>Background: Clinical FDG/PET (2-deoxy-2- 18 F-fluoro-D-glucose/positron emission tomography) studies encounter difficulties in detecting early stage lung cancers. The aim of this study was to evaluate the ability of O-2- 18 F-fluoroethyl-L-tyrosine (FET) and FDG to differentiate between inflammation and lung carcinoma in mice. Materials and Methods: Sixty-four C57BL/6 mice were inoculated with 2x10 6 LLC1 lung carcinoma cells in the right hind flank on day 0 and were then injected with 0.1 mL turpentine in the left thigh muscle on day 3. The progress of inflammation and tumor in mice was longitudinally monitored by FDG/microPET. The biodistribution study, pharmacokinetic evaluation and whole-body autoradiography of FET and FDG were performed on day 8 after tumor inoculation. Results: The FDG uptakes in tumor and inflammatory lesions were 4.42-fold and 3.53-fold (n=4) higher, respectively, than that in muscle at 90 min post-injection and the tumor-to-inflammation ratio was 1.25. For FET/microPET, the tumor uptake was 2.07-fold and 2.07-fold (n=4) higher than those in muscle and inflammatory lesions at 90 min post-injection, respectively. The distribution half-life (t 1/2,α ) and the elimination half-life (t 1/2,β ) of FET were 39 min and 205 min, respectively, in mice. Conclusion: FDG delineated both tumor and inflammation, while FET accumulated in tumor to a significantly higher extent. Our results demonstrated the potential of FET to distinguish epidermoid lung carcinoma from inflammatory lesions in mice.</abstract><cop>Attiki</cop><pub>International Institute of Anticancer Research</pub><pmid>16619487</pmid><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0250-7005
ispartof Anticancer research, 2006-03, Vol.26 (2A), p.917-925
issn 0250-7005
1791-7530
language eng
recordid cdi_pubmed_primary_16619487
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects Animals
Autoradiography - methods
Biological and medical sciences
Carcinoma, Lewis Lung - diagnostic imaging
Carcinoma, Lewis Lung - metabolism
Carcinoma, Non-Small-Cell Lung - diagnostic imaging
Carcinoma, Non-Small-Cell Lung - metabolism
Diagnosis, Differential
Fluorine Radioisotopes
Fluorodeoxyglucose F18 - pharmacokinetics
Image Processing, Computer-Assisted
Lung Neoplasms - diagnostic imaging
Lung Neoplasms - metabolism
Male
Medical sciences
Mice
Mice, Inbred C57BL
Pneumology
Pneumonia - chemically induced
Pneumonia - diagnostic imaging
Pneumonia - metabolism
Positron-Emission Tomography - methods
Radiopharmaceuticals - pharmacokinetics
Tumors
Tumors of the respiratory system and mediastinum
Turpentine
Tyrosine - analogs & derivatives
Tyrosine - pharmacokinetics
title Comparative Evaluation of FET and FDG for Differentiating Lung Carcinoma from Inflammation in Mice
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T05%3A29%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_pasca&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Comparative%20Evaluation%20of%20FET%20and%20FDG%20for%20Differentiating%20Lung%20Carcinoma%20from%20Inflammation%20in%20Mice&rft.jtitle=Anticancer%20research&rft.au=CHANG,%20Chih-Hsien&rft.date=2006-03-01&rft.volume=26&rft.issue=2A&rft.spage=917&rft.epage=925&rft.pages=917-925&rft.issn=0250-7005&rft.eissn=1791-7530&rft_id=info:doi/&rft_dat=%3Cpubmed_pasca%3E16619487%3C/pubmed_pasca%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/16619487&rfr_iscdi=true